n.a. (SHP)

0.00
NYSE
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] Data Demonstrate Improved Treatment Satisfaction Relative To Patients' Previous Immunoglobulin Therapy

CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] Data Demonstrate Improved Treatment Satisfaction Relative To Patients' Previous Immunoglobulin Therapy

Shire data presentations at AAAAI 2017 reinforce the efficacy, safety, and tolerability of CUVITRU for primary immunodeficiency patients

New Data From Shire Aim To Help Close The Diagnosis And Treatment Gap For People With Hemophilia

New Data From Shire Aim To Help Close The Diagnosis And Treatment Gap For People With Hemophilia

Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care

Shire To Establish Rare Disease Innovation Hub In Cambridge, Mass.

Shire To Establish Rare Disease Innovation Hub In Cambridge, Mass.

Company to expand into 500 Kendall Street and create a 550,000-square-foot campus focused on rare diseases and highly specialized conditions

Results From Shire's Phase 2 Study Of Maribavir Showed Activity Against CMV Infection In Patients Undergoing Transplant

Results From Shire's Phase 2 Study Of Maribavir Showed Activity Against CMV Infection In Patients Undergoing Transplant

Data support progressing with Phase 3 clinical development program

Invest in Allergan on Weakness, Analysts Say

Invest in Allergan on Weakness, Analysts Say

Pharmaceutical giant Allergan looks poised to have a great year in 2017.

Multimedia Assets Available: Modern Technology And A Multi-Screen Lifestyle Viewed As Important Factors In Rising Prevalence Of Dry Eye Disease

Multimedia Assets Available: Modern Technology And A Multi-Screen Lifestyle Viewed As Important Factors In Rising Prevalence Of Dry Eye Disease

-- Results from the National Eye C.A.R.E. Survey reinforce potential link between tech-dependency and growing risk of dry eye disease